Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.
Our Mission DTx Pharma is developing technology that will unleash RNA-based therapeutics as the modality of choice for personalized treatment across most therapeutic areas. Contact us for more informa
All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.
How it describes itself
Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.
Seen November 2026 · 1 capture · latest observed messagingReimagining medicine, together.
For more than 250 years–and 30 years as Novartis–we’ve pursued scientific breakthroughs for one purpose: people. Today, we take on the toughest challenges in healthcare and turn innovations into medic
July 2021 – February 2025 · 5 capturesBreaking open new therapeutic areas for RNA medicines
DTx Pharma is a clinical-stage biotechnology company tackling the challenges associated with treating genetic conditions by leveraging RNA-based therapeutics.
9 July 2021 · Taking RNA Medicines to New Heightsarchived page
26 September 2022 · Taking RNA Medicines to New Heightsarchived page
27 January 2023 · Breaking open new therapeutic areas for RNA medicinesarchived page
3 December 2024 · Breaking open new therapeutic areas for RNA medicinesarchived page
20 February 2025 · Breaking open new therapeutic areas for RNA medicinesarchived page
June 2020 – January 2021 · 2 capturesEnabling Precision Medicine
At DTx we’re inspired to improve the lives of patients suffering from rare and chronic diseases worldwide by introducing next-generation, safe and effective medicines based on fatty acid motifs that d